Masferrer J L, Zweifel B S, Seibert K, Needleman P
Department of Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110.
J Clin Invest. 1990 Oct;86(4):1375-9. doi: 10.1172/JCI114850.
We have studied the effect of glucocorticoids administered in vivo on the activity and synthesis of the cyclooxygenase enzyme (COX) in mice treated with or without concurrent intravenous administration of LPS. Mouse peritoneal macrophages from LPS-treated animals showed a two to three fold increase in COX activity determined by the production of PGE2 and PGI2 after stimulation of the cells with exogenous arachidonate. Dexamethasone injected simultaneously with LPS, 12 h before killing of the animal and removal of the macrophages, completely blocked the LPS-induced increase COX activity in peritoneal macrophages. The regulation observed in COX activity by LPS and dexamethasone are due primarily to changes in COX mass as determined by immunoprecipitation of [35S]methionine endogenously labeled enzyme. In contrast, the COX present in the nonadherent cells and in renal medullary microsomes obtained from the same animals, showed no significant changes between treatments. These results indicate that LPS in vivo stimulates COX synthesis in the peritoneal macrophages but not in the kidney. The effect of dexamethasone to inhibit COX synthesis is selective to the LPS-induced enzyme.
我们研究了体内给予糖皮质激素对经或未经静脉注射脂多糖(LPS)处理的小鼠体内环氧化酶(COX)活性及合成的影响。来自经LPS处理动物的小鼠腹腔巨噬细胞,在用外源性花生四烯酸刺激细胞后,通过PGE2和PGI2的产生测定,其COX活性增加了两到三倍。在处死动物并分离巨噬细胞前12小时,与LPS同时注射地塞米松,可完全阻断LPS诱导的腹腔巨噬细胞COX活性增加。LPS和地塞米松对COX活性的调节主要是由于通过对[35S]甲硫氨酸内源性标记酶进行免疫沉淀所确定的COX含量的变化。相比之下,从同一动物获得的非贴壁细胞和肾髓质微粒体中的COX,在不同处理之间未显示出显著变化。这些结果表明,体内LPS刺激腹腔巨噬细胞中的COX合成,但不刺激肾脏中的COX合成。地塞米松抑制COX合成的作用对LPS诱导的酶具有选择性。